Literature DB >> 21901840

Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism.

S Hossein Fatemi1, Timothy D Folsom, Rachel E Kneeland, Stephanie B Liesch.   

Abstract

Recent work has demonstrated the impact of dysfunction of the GABAergic signaling system in brain and the resultant behavioral pathologies in subjects with autism. In animal models, altered expression of Fragile X mental retardation protein (FMRP) has been linked to downregulation of GABA receptors. Interestingly, the autistic phenotype is also observed in individuals with Fragile X syndrome. This study was undertaken to test previous theories relating abnormalities in levels of FMRP to GABA(A) receptor underexpression. We observed a significant reduction in levels of FMRP in the vermis of adults with autism. Additionally, we found that levels of metabotropic glutamate receptor 5 (mGluR5) protein were significantly increased in vermis of children with autism versus age and postmortem interval matched controls. There was also a significant decrease in level of GABA(A) receptor beta 3 (GABRβ3) protein in vermis of adult subjects with autism. Finally, we found significant increases in glial fibrillary acidic protein in vermis of both children and adults with autism when compared with controls. Taken together, our results provide further evidence that altered FMRP expression and increased mGluR5 protein production potentially lead to altered expression of GABA(A) receptors.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901840      PMCID: PMC3177171          DOI: 10.1002/ar.21299

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  76 in total

1.  The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains.

Authors:  A Oka; S Takashima
Journal:  Acta Neuropathol       Date:  1999-03       Impact factor: 17.088

2.  Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.

Authors:  Rodney C Samaco; Amber Hogart; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2004-12-22       Impact factor: 6.150

3.  Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.

Authors:  Peter Naur; Bente Vestergaard; Lars K Skov; Jan Egebjerg; Michael Gajhede; Jette Sandholm Kastrup
Journal:  FEBS Lett       Date:  2005-02-14       Impact factor: 4.124

4.  Epilepsy and EEG findings in males with fragile X syndrome.

Authors:  S A Musumeci; R J Hagerman; R Ferri; P Bosco; B Dalla Bernardina; C A Tassinari; G B De Sarro; M Elia
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

5.  Reelin signaling is impaired in autism.

Authors:  S Hossein Fatemi; Anne V Snow; Joel M Stary; Mohsen Araghi-Niknam; Teri J Reutiman; Suzanne Lee; Andrew I Brooks; David A Pearce
Journal:  Biol Psychiatry       Date:  2005-04-01       Impact factor: 13.382

6.  Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis.

Authors:  Scott A Irwin; Chariya A Christmon; Aaron W Grossman; Roberto Galvez; Soong Ho Kim; Brian J DeGrush; Ivan Jeanne Weiler; William T Greenough
Journal:  Neurobiol Learn Mem       Date:  2005-05       Impact factor: 2.877

7.  Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.

Authors:  Abdeslem El Idrissi; Xiao-Hua Ding; Jason Scalia; Ekkhart Trenkner; W Ted Brown; Carl Dobkin
Journal:  Neurosci Lett       Date:  2004-12-23       Impact factor: 3.046

Review 8.  Neuropathological findings in autism.

Authors:  Saskia J M C Palmen; Herman van Engeland; Patrick R Hof; Christoph Schmitz
Journal:  Brain       Date:  2004-08-25       Impact factor: 13.501

9.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Neuroglial activation and neuroinflammation in the brain of patients with autism.

Authors:  Diana L Vargas; Caterina Nascimbene; Chitra Krishnan; Andrew W Zimmerman; Carlos A Pardo
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

View more
  61 in total

1.  Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome.

Authors:  Lindsay Oberman; Mark Eldaief; Shirley Fecteau; Fritz Ifert-Miller; Jose Maria Tormos; Alvaro Pascual-Leone
Journal:  Eur J Neurosci       Date:  2012-06-28       Impact factor: 3.386

2.  Fragile X mental retardation protein levels are decreased in major psychiatric disorders.

Authors:  S Hossein Fatemi; Rachel E Kneeland; Stephanie B Liesch; Timothy D Folsom
Journal:  Schizophr Res       Date:  2010-08-19       Impact factor: 4.939

3.  Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens.

Authors:  Peter H Frederikse; Anoop Nandanoor; Chinnaswamy Kasinathan
Journal:  Neurochem Res       Date:  2015-08-23       Impact factor: 3.996

4.  Translational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells.

Authors:  Se Jin Jeon; Ji-Woon Kim; Ki Chan Kim; So Min Han; Hyo Sang Go; Jung Eun Seo; Chang Soon Choi; Jong Hoon Ryu; Chan Young Shin; Mi-Ryoung Song
Journal:  Cell Mol Neurobiol       Date:  2013-12-12       Impact factor: 5.046

Review 5.  Sensory perception in autism.

Authors:  Caroline E Robertson; Simon Baron-Cohen
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

Review 6.  Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Authors:  Sabina Berretta; Stephan Heckers; Francine M Benes
Journal:  Schizophr Res       Date:  2014-11-11       Impact factor: 4.939

Review 7.  GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Res       Date:  2014-11-26       Impact factor: 4.939

8.  The effects of prenatal H1N1 infection at E16 on FMRP, glutamate, GABA, and reelin signaling systems in developing murine cerebellum.

Authors:  S Hossein Fatemi; Timothy D Folsom; Stephanie B Liesch; Rachel E Kneeland; Mahtab Karkhane Yousefi; Paul D Thuras
Journal:  J Neurosci Res       Date:  2016-10-13       Impact factor: 4.164

9.  Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study.

Authors:  Mark S Brown; Debra Singel; Susan Hepburn; Donald C Rojas
Journal:  Autism Res       Date:  2012-11-16       Impact factor: 5.216

10.  Transcriptional corepressor SIN3A regulates hippocampal synaptic plasticity via Homer1/mGluR5 signaling.

Authors:  Morgan Bridi; Hannah Schoch; Cédrick Florian; Shane G Poplawski; Anamika Banerjee; Joshua D Hawk; Giulia S Porcari; Camille Lejards; Chang-Gyu Hahn; Karl-Peter Giese; Robbert Havekes; Nelson Spruston; Ted Abel
Journal:  JCI Insight       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.